New Search

If you are not happy with the results below please do another search

1271 search results for:

81

Global Access Diagnostics reintroduces IT-Leish test for visceral leishmaniasis

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, has introduced IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for IT-Leish from Bio-Rad in September 2022 to prevent its withdrawal from the market and has since ensured the regulatory requirements have been met for reintroduction […]

82

Tecan’s Phase Separator advances automation for liquid biopsy and biobanking

Tecan has unveiled its Phase Separator, an innovative liquid separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.

83

Gyros Protein Technologies introduces PurePep EasyClean Auto Kit for automated parallel peptide purification

Gyros Protein Technologies, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanolitre-scale immunoassays, has launched PurePep EasyClean (PEC) Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.

85

Sartorius and Repligen Corporation introduce integrated system with Biostat STR and XCell ATF for upstream process intensification

The life science group Sartorius and Repligen Corporation have launched of an integrated bioreactor system that incorporates Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor, simplifying intensified seed train and N perfusion implementation for biopharmaceuti­cal manufacturers. The Biostat STR now contains a fully compatible embedded XCell ATF hardware and software module offering […]

86

Waters launches XBridge Premier GTx BEH SEC Columns for gene therapy applications

Waters Corporation has introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors. The new Waters XBridge Premier GTx BEH SEC columns doubles the speed of measuring the potency and safety of AAVs. Combining the […]